Skip to content
World Cup 2023: Fakhar fires as Pakistan beat New Zealand in rain-hit match

World Cup 2023: Fakhar fires as Pakistan beat New Zealand in rain-hit match

Chasing 402 to win the high-stakes clash, Pakistan took the attack to New Zealand as Fakhar hit a blistering century off 63 balls and Babar Azam inched towards his fifty when rain halted play

Read More

​ Chasing 402 to win the high-stakes clash, Pakistan took the attack to New Zealand as Fakhar hit a blistering century off 63 balls and Babar Azam inched towards his fifty when rain halted play Chasing 402 to win the high-stakes clash, Pakistan took the attack to New Zealand as Fakhar hit a blistering century off 63 balls and Babar Azam inched towards his fifty when rain halted play  Moneycontrol Latest News Read More  

Chasing 402 to win the high-stakes clash, Pakistan took the attack to New Zealand as Fakhar hit a blistering century off 63 balls and Babar Azam inched towards his fifty when rain halted play

Buy Titan Company; target of Rs 3740: Sharekhan

Buy Titan Company; target of Rs 3740: Sharekhan

Sharekhan is bullish on Titan Company has recommended buy rating on the stock with a target price of Rs 3740 in its research report dated October 03, 2023.

Read More

​ Sharekhan is bullish on Titan Company has recommended buy rating on the stock with a target price of Rs 3740 in its research report dated October 03, 2023. Sharekhan is bullish on Titan Company has recommended buy rating on the stock with a target price of Rs 3740 in its research report dated October 03, 2023.  Moneycontrol Latest News Read More  

Sharekhan is bullish on Titan Company has recommended buy rating on the stock with a target price of Rs 3740 in its research report dated October 03, 2023.

Buy Cholamandalam Investment and Finance Company; target of Rs 1350: Sharekhan

Buy Cholamandalam Investment and Finance Company; target of Rs 1350: Sharekhan

Sharekhan is bullish on Cholamandalam Investment and Finance Company has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated October 03, 2023.

Read More

​ Sharekhan is bullish on Cholamandalam Investment and Finance Company has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated October 03, 2023. Sharekhan is bullish on Cholamandalam Investment and Finance Company has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated October 03, 2023.  Moneycontrol Latest News Read More  

Sharekhan is bullish on Cholamandalam Investment and Finance Company has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated October 03, 2023.

Metropolis Healthcare Q2 results: Net Profit down 11.9% to Rs 35.5 crore

Metropolis Healthcare Q2 results: Net Profit down 11.9% to Rs 35.5 crore

The diagnostic services provider#39;s operations predominantly relate to providing diagnostic services in pathology services.

Read More

​ The diagnostic services provider#39;s operations predominantly relate to providing diagnostic services in pathology services. The diagnostic services provider#39;s operations predominantly relate to providing diagnostic services in pathology services.  Moneycontrol Latest News Read More  

The diagnostic services provider#39;s operations predominantly relate to providing diagnostic services in pathology services.

Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix

Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix

A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs

Read More

​ A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs  Moneycontrol Latest News Read More  

A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs

Cello World to debut on November 6: Stock may list at 22-25% premium over IPO price

Cello World to debut on November 6: Stock may list at 22-25% premium over IPO price

Analysts expect the Cello World#39;s stock to open somewhere between Rs 790 and Rs 810 against the IPO price of Rs 648

Read More

​ Analysts expect the Cello World#39;s stock to open somewhere between Rs 790 and Rs 810 against the IPO price of Rs 648 Analysts expect the Cello World#39;s stock to open somewhere between Rs 790 and Rs 810 against the IPO price of Rs 648  Moneycontrol Latest News Read More  

Analysts expect the Cello World#39;s stock to open somewhere between Rs 790 and Rs 810 against the IPO price of Rs 648

IPO Weekly Wrap: Mamaearth, ESAF, Cello, Blue Jet and 12 SMEs steer the market ship

IPO Weekly Wrap: Mamaearth, ESAF, Cello, Blue Jet and 12 SMEs steer the market ship

Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their public issues this week

Read More

​ Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their public issues this week Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their public issues this week  Moneycontrol Latest News Read More  

Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their public issues this week

Vedanta Q2 results: Net loss of Rs 915 crore despite strong EBITDA

Vedanta Q2 results: Net loss of Rs 915 crore despite strong EBITDA

Vedanta Q2 earnings: Despite reporting a net loss in Q2, Vedanta managed to showcase a strong improvement in operational performance as EBITDA margin expanded to 28.7 percent.

Read More

​ Vedanta Q2 earnings: Despite reporting a net loss in Q2, Vedanta managed to showcase a strong improvement in operational performance as EBITDA margin expanded to 28.7 percent. Vedanta Q2 earnings: Despite reporting a net loss in Q2, Vedanta managed to showcase a strong improvement in operational performance as EBITDA margin expanded to 28.7 percent.  Moneycontrol Latest News Read More  

Vedanta Q2 earnings: Despite reporting a net loss in Q2, Vedanta managed to showcase a strong improvement in operational performance as EBITDA margin expanded to 28.7 percent.

One billion bipedal robots to AI-based doctors: Ace entrepreneur Vinod Khosla#39;s predictions for upcoming decades

One billion bipedal robots to AI-based doctors: Ace entrepreneur Vinod Khosla#39;s predictions for upcoming decades

Right from the growth of one billion bipedal robots in the next 25 years to finding efficient sources of plant protein to replace animal protein, these predictions mostly encircle technology and AI that will soon reinvent societal structure.

Read More

​ Right from the growth of one billion bipedal robots in the next 25 years to finding efficient sources of plant protein to replace animal protein, these predictions mostly encircle technology and AI that will soon reinvent societal structure. Right from the growth of one billion bipedal robots in the next 25 years to finding efficient sources of plant protein to replace animal protein, these predictions mostly encircle technology and AI that will soon reinvent societal structure.  Moneycontrol Latest News Read More  

Right from the growth of one billion bipedal robots in the next 25 years to finding efficient sources of plant protein to replace animal protein, these predictions mostly encircle technology and AI that will soon reinvent societal structure.

Unsecured loans not a worry for SBI, says Chairman Dinesh Khara

Unsecured loans not a worry for SBI, says Chairman Dinesh Khara

The bank has a total unsecured book of Rs 3.2 lakh crore as of September 30, 2023, Khara said. He added that the bank#39;s gross-non-performing asset is at 0.69 percent

Read More

​ The bank has a total unsecured book of Rs 3.2 lakh crore as of September 30, 2023, Khara said. He added that the bank#39;s gross-non-performing asset is at 0.69 percent The bank has a total unsecured book of Rs 3.2 lakh crore as of September 30, 2023, Khara said. He added that the bank#39;s gross-non-performing asset is at 0.69 percent  Moneycontrol Latest News Read More  

The bank has a total unsecured book of Rs 3.2 lakh crore as of September 30, 2023, Khara said. He added that the bank#39;s gross-non-performing asset is at 0.69 percent

en_USEnglish